泽璟制药-U
(688266)
| 流通市值：145.85亿 | | | 总市值：145.85亿 |
| 流通股本：2.65亿 | | | 总股本：2.65亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,989,124,501.13 | 2,109,640,875.32 | 1,925,597,425.55 | 1,576,392,843.66 |
| 应收票据及应收账款 | 112,023,076.65 | 101,139,998.16 | 89,894,945.42 | 109,845,898.18 |
| 应收账款 | 112,023,076.65 | 101,139,998.16 | 89,894,945.42 | 109,845,898.18 |
| 预付款项 | 51,902,096.75 | 46,250,585.38 | 54,685,790.53 | 51,422,047.49 |
| 其他应收款合计 | 10,227,345.34 | 10,894,988.6 | 11,005,240.6 | 10,997,509.23 |
| 存货 | 130,430,627.8 | 110,852,343.86 | 114,794,994.21 | 111,048,126.26 |
| 其他流动资产 | 3,514,558.6 | 4,538,472.24 | 4,341,161.25 | 3,182,048.44 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,722,994,152.5 | 2,520,336,094.4 | 2,499,759,209.72 | 2,510,460,495.25 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 5,987,768.53 | 5,987,768.53 | 10,000,000 | 10,000,000 |
| 固定资产 | 95,022,401.79 | 98,289,417.59 | 117,146,934.71 | 107,229,575.92 |
| 在建工程 | 154,687,504.89 | 135,826,970.65 | 87,208,176.9 | 95,406,531.42 |
| 使用权资产 | 42,396,966.14 | 37,088,669.86 | 40,274,911.43 | 43,499,633.72 |
| 无形资产 | 64,377,650.12 | 69,269,782.52 | 73,107,243.06 | 78,604,635.65 |
| 长期待摊费用 | 15,222,027.66 | 16,390,550.81 | 17,398,676.4 | 18,797,016.06 |
| 其他非流动资产 | 4,059,481.31 | 4,017,570.95 | 14,166,748.87 | 6,963,196.78 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 381,753,800.44 | 366,870,730.91 | 359,302,691.37 | 360,500,589.55 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,104,747,952.94 | 2,887,206,825.31 | 2,859,061,901.09 | 2,870,961,084.8 |
| 流动负债: | | | | |
| 短期借款 | 953,387,099.71 | 795,164,810.85 | 759,005,597.4 | 658,978,977.96 |
| 应付票据及应付账款 | 122,207,712.81 | 137,734,514.83 | 117,618,984.46 | 119,219,874.68 |
| 应付账款 | 122,207,712.81 | 137,734,514.83 | 117,618,984.46 | 119,219,874.68 |
| 预收款项 | 84,097.86 | 107,033.64 | - | - |
| 合同负债 | - | - | 202,535.79 | 152,905.2 |
| 应付职工薪酬 | 53,796,138.5 | 65,250,987.29 | 55,720,368.79 | 48,340,227.34 |
| 应交税费 | 29,945,038.58 | 33,015,290.95 | 26,352,510.5 | 32,782,396.38 |
| 其他应付款合计 | 32,242,210.44 | 30,134,274.18 | 24,747,646.68 | 23,192,884.07 |
| 一年内到期的非流动负债 | 13,916,453.55 | 63,732,890.83 | 63,680,002.17 | 63,525,224.38 |
| 其他流动负债 | 2,611,074.14 | 10,041,434.3 | 3,569,519.71 | 2,000,000 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,208,189,825.59 | 1,135,181,236.87 | 1,050,897,165.5 | 948,192,490.01 |
| 非流动负债: | | | | |
| 租赁负债 | 31,525,903.95 | 29,455,850.25 | 29,150,434.87 | 30,946,409.91 |
| 递延收益 | 10,430,686.62 | 11,545,978.09 | 18,860,819.65 | 39,440,977.8 |
| 递延所得税负债 | 8,606,520.01 | 9,582,937.93 | 10,719,243.88 | 11,799,288.02 |
| 其他非流动负债 | 245,283,019.8 | 56,603,773.8 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 295,846,130.38 | 107,188,540.07 | 58,730,498.4 | 82,186,675.73 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,504,035,955.97 | 1,242,369,776.94 | 1,109,627,663.9 | 1,030,379,165.74 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 264,708,186 | 264,708,186 | 264,708,186 | 264,689,736 |
| 资本公积 | 3,353,266,259.9 | 3,353,006,007.66 | 3,371,288,592.91 | 3,368,658,344.74 |
| 其他综合收益 | -5,869,772.59 | -5,949,767.5 | -1,438,211.41 | -1,173,215.84 |
| 未分配利润 | -2,018,411,091.49 | -1,978,911,708.48 | -1,902,418,374.08 | -1,814,557,690.95 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,593,693,581.82 | 1,632,852,717.68 | 1,732,140,193.42 | 1,817,617,173.95 |
| 少数股东权益 | 7,018,415.15 | 11,984,330.69 | 17,294,043.77 | 22,964,745.11 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,600,711,996.97 | 1,644,837,048.37 | 1,749,434,237.19 | 1,840,581,919.06 |
| 负债和股东权益合计 | 3,104,747,952.94 | 2,887,206,825.31 | 2,859,061,901.09 | 2,870,961,084.8 |
| 公告日期 | 2024-04-20 | 2024-04-20 | 2023-10-28 | 2023-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |